相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2019)
Treatment for refractory lupus nephritis: Rituximab vs triple target therapy
Ricard Cervera et al.
AUTOIMMUNITY REVIEWS (2019)
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis
Gabriella Moroni et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
Liliana Michelle Gomez Mendez et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015 A Systematic Review and Bayesian Meta-Analysis
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment
Dario Roccatello et al.
AUTOIMMUNITY REVIEWS (2015)
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Marie B. Condon et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus
C. C. Mok et al.
ARTHRITIS AND RHEUMATISM (2013)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy
Dario Roccatello et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
B-cell targeted therapies in human autoimmune diseases: an updated perspective
Michael J. Townsend et al.
IMMUNOLOGICAL REVIEWS (2010)
Long-Term Mortality and Renal Outcome in a Cohort of 100 Patients With Lupus Nephritis
Mikkel Faurschou et al.
ARTHRITIS CARE & RESEARCH (2010)
B Cells and Immunological Tolerance
Nataly Manjarrez-Orduno et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
分享论文
